Department of Laboratory Medicine, Boston Children's Hospital, Boston, Massachusetts.
Department of Pathology, Harvard Medical School, Boston, Massachusetts.
Thyroid. 2020 Mar;30(3):365-379. doi: 10.1089/thy.2019.0167. Epub 2020 Feb 14.
Uncertainty in the mechanism and directionality of observational associations between thyroid function and kidney function may be addressed by genetic analysis with an instrumental variable method termed bidirectional Mendelian randomization (MR). In the Women's Genome Health Study (WGHS), observational associations between thyroid measures and kidney function were evaluated. Genetic instruments for MR were from recent genome-wide association studies (GWAS) of hypothyroidism, thyrotropin (TSH), and free thyroxine (fT4) concentrations within the reference range, thyroid peroxidase antibodies (TPOAb), estimated glomerular filtration rate from creatinine (eGFR), eGFR from cystatin C (eGFR), and chronic kidney disease (CKD). In WGHS individual-level data, these instruments were used for bidirectional MR between thyroid ( = 3336) and kidney ( = 23,186) functions. To increase power, MR was also performed using GWAS summary statistics from the Chronic Kidney Disease Genetics Consortium (CKDGen) for eGFR ( = 567,460), eGFR ( = 24,063), CKD [(total) = 480,698, (cases) = 41,395], and urinary albumin/creatinine ratio (UACR/ = 54,450). In the WGHS, hypothyroidism was observationally associated with decreased eGFR [beta (standard error, SE): -0.024 (0.009) ln(mL/min/1.73 m), = 0.01]. By MR, hypothyroidism was associated with decreased eGFR in the WGHS [beta (SE): -0.007 (0.002) per doubled odds hypothyroidism, = 1.7 × 10] and in CKDGen [beta (SE): -0.004 (0.0005), = 2.0 × 10], and robust to sensitivity analysis. Hypothyroidism was also associated by MR with increased CKD in CKDGen (odds ratio, OR [confidence interval, CI]: 1.05 [1.03-1.08], = 3.3 × 10), but not in the WGHS (OR [CI]: 1.02 [0.95-1.10], = 0.57). Increased TSH within the reference range had an MR association with increased eGFR in the WGHS [beta (SE): -0.018 (0.007) ln(mL/min/1.73 m)/standard deviation, SD, = 6.5 × 10] and CKDGen [beta (SE): -0.008 (0.001) ln(mL/min/1.73 m)/SD, = 6.8 × 10], and with CKD in CKDGen (OR [CI]: 1.10 [1.04-1.15], = 3.1 × 10). There were no MR associations of hypothyroidism or TSH with eGFR or UACR, and MR associations of fT4 in the reference range with kidney function were inconsistent in both the WGHS and CKDGen. However, by MR in CKDGen, TPOAb were robustly associated with decreased eGFR [beta (SE): -0.041 (0.009), = 6.2 × 10] and decreased eGFR [beta (SE): -0.294 (0.065), = 6.2 × 10]. TPOAb were less robustly associated with CKD but not associated with UACR. In reverse MR in the WGHS, kidney function was not consistently associated with thyroid function. Bidirectional MR supports a directional association from hypothyroidism, increased TSH, and TPOAb, but not fT4, to decreased eGFR and increased CKD.
甲状腺功能与肾功能之间的观察性关联的机制和方向性的不确定性,可以通过一种称为双向孟德尔随机化(MR)的遗传分析方法来解决。在女性基因组健康研究(WGHS)中,评估了甲状腺测量值与肾功能之间的观察性关联。MR 的遗传工具来自最近的甲状腺功能减退症、促甲状腺激素(TSH)和游离甲状腺素(fT4)在参考范围内的浓度、甲状腺过氧化物酶抗体(TPOAb)、基于肌酐的估计肾小球滤过率(eGFR)、基于胱抑素 C 的 eGFR(eGFR)和慢性肾脏病(CKD)的全基因组关联研究(GWAS)。在 WGHS 个体水平数据中,这些工具用于甲状腺( = 3336)和肾脏( = 23186)功能之间的双向 MR。为了增加统计功效,还使用慢性肾脏病遗传学联合会(CKDGen)的 GWAS 汇总统计数据进行了 MR,用于 eGFR( = 567460)、eGFR( = 24063)、CKD [总()= 480698,病例()= 41395]和尿白蛋白/肌酐比(UACR/= 54450)。在 WGHS 中,观察到甲状腺功能减退症与 eGFR 降低相关[β(标准误差,SE):-0.024(0.009)ln(mL/min/1.73 m), = 0.01]。通过 MR,甲状腺功能减退症与 WGHS 中的 eGFR 降低相关[β(SE):-0.007(0.002)每双倍几率甲状腺功能减退症, = 1.7×10]和 CKDGen [β(SE):-0.004(0.0005), = 2.0×10],且对敏感性分析具有稳健性。MR 还表明,甲状腺功能减退症与 CKDGen 中的 CKD 增加相关(优势比,OR [置信区间,CI]:1.05 [1.03-1.08], = 3.3×10),但在 WGHS 中没有(OR [CI]:1.02 [0.95-1.10], = 0.57)。参考范围内的 TSH 增加与 WGHS 中 eGFR 的 MR 关联[β(SE):-0.018(0.007)ln(mL/min/1.73 m)/SD, = 6.5×10]和 CKDGen [β(SE):-0.008(0.001)ln(mL/min/1.73 m)/SD, = 6.8×10],以及 CKDGen 中的 CKD 相关(OR [CI]:1.10 [1.04-1.15], = 3.1×10)。MR 没有显示甲状腺功能减退症或 TSH 与 eGFR 或 UACR 的关联,而参考范围内的 fT4 与肾功能的关联在 WGHS 和 CKDGen 中均不一致。然而,在 CKDGen 的 MR 中,TPOAb 与 eGFR 的降低[β(SE):-0.041(0.009), = 6.2×10]和 eGFR 的降低[β(SE):-0.294(0.065), = 6.2×10]显著相关。TPOAb 与 CKD 的关联稍弱,但与 UACR 无关。在 WGHS 的反向 MR 中,肾功能与甲状腺功能之间没有一致的关联。双向 MR 支持从甲状腺功能减退症、TSH 增加和 TPOAb 到 eGFR 降低和 CKD 增加的方向性关联,但不支持 fT4。